MERCURYLABPharmaceuticals
Mercury Labs — Quarterly Results & Earnings
₹860.00
+0.00%
Profit Growth YoY228.00%Latest quarter
Sales Growth YoY4.51%Latest quarter
Sales CAGR 5Y5.57%5 year compound
Profit CAGR 5Y-0.82%5 year compound
📋
Quarterly Performance
YoY Profit Growth+228.00%
🔥 Exceptional growth
YoY Sales Growth+4.51%
📈 Moderate growth
OPM 5Y Average
11.70%Operating profit margin
EPS Growth 5Y
-0.82%Interest Coverage
13.17Higher = safer debt servicing
ROE
5.94%ROCE
8.94%💡
Growth Analysis
Mercury Labs reported YoY profit growth of 228.00% and revenue growth of 4.51% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 5.57% and profits at -0.82% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Mercury Labs
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.